From a biochemical therapeutics standpoint, Relafen 750 (Naproxen ) presents a fascinating case study in therapeutic action. Its mechanism of effect primarily involves the inhibition of cyclooxygenase (COX ) enzymes, particularly COX-2 , leading to a decrease in the synthesis of prostaglandins . This selective inhibition accounts for its pain-relie